CN Patent

CN102924322B — 一种替加环素的新晶型及其制备方法

Assigned to Hebei Zhiheng Pharmaceutical Technology Co ltd · Expires 2014-09-17 · 12y expired

What this patent protects

本发明属于医药技术领域，涉及一种替加环素的新晶型及其制备方法，其在X-射线粉末衍射图上具有以下衍射峰：4.6；6.2；6.6；8.8；9.3；9.6；12.0；12.4；13.6；17.6；18.0；20.0；21.4；23.2；26.6，上述衍射峰的偏差值为±0.2°。

USPTO Abstract

本发明属于医药技术领域，涉及一种替加环素的新晶型及其制备方法，其在X-射线粉末衍射图上具有以下衍射峰：4.6；6.2；6.6；8.8；9.3；9.6；12.0；12.4；13.6；17.6；18.0；20.0；21.4；23.2；26.6，上述衍射峰的偏差值为±0.2°。

Drugs covered by this patent

Patent Metadata

Patent number
CN102924322B
Jurisdiction
CN
Classification
—
Expires
2014-09-17
Drug substance claim
No
Drug product claim
No
Assignee
Hebei Zhiheng Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.